
Setara Biosciences Raises $90M Series A to Advance Rare Disease Therapies
Setara Biosciences Secures $90 Million Series A Financing to Advance Precision Medicines for Rare Genetic Diseases Setara Biosciences, Inc., a clinical-stage biotechnology company focused on developing precision medicines for severe…














